Three months after beginning therapy with a GLP-1 receptor a…
Three months after beginning therapy with a GLP-1 receptor agonist, a client returns for follow-up evaluation. The provider reviews laboratory results and recent health changes to determine whether treatment goals are being achieved. Which finding most strongly suggests the medication is producing the intended therapeutic effect?